Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9498476
APP PUB NO 20150366864A1
SERIAL NO

14841024

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure generally relates to a crystalline form of 6-[(4S)-2-methyl-4-(naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine. The present disclosure also generally relates to pharmaceutical compositions comprising the crystalline form, as well of methods of using a crystalline form in the treatment of depression and other conditions and methods for obtaining such crystalline form.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ALBANY MOLECULAR RESEARCH, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Amin, Rasidul East Greenbush, US 18 26
Gao, Qi Franklin Park, US 83 483
Hu, Min Schenectady, US 110 691
Isherwood, Matthew Del Mar, US 8 37
Liu, Shuang Schenectady, US 193 1607
Qiu, Jun Kendall Park, US 47 490
Yang, Yuh-Lin Allen Bay Point, US 7 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 22, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00